Portal de Periódicos da CAPES

Ansiedad, depresión y deshabituación tabáquica.

2016; Volume: 29; Issue: 4 Linguagem: Inglês

10.20882/adicciones.761

2604-6334

Virginia Almadana Pacheco, Ana Paulina Gómez‐Bastero Fernández, Agustín Valido Morales, Estefanía Luque Crespo, Soledad Monserrat, Teodoro Montemayor Rubio,

Psychological Treatments and Disorders

There is evidence of the relationship between mental illness and smoking and increased risk of depressive episodes after quitting smoking, even with specific treatments for abstinence. Objective: To assess the influence of a cessation program on the emotional state of patients by measuring levels of anxiety / depression and differences depending on the presence of psychiatric history. Method: A prospective observational study of patients taking part in a combined program (pharmacological and cognitive-behavioral) for giving up smoking. Anxiety (A) and depression (D) were measured using the HADS questionnaire at baseline, first and third month of abstinence. Results: Anxiety and depression showed significant and progressive improvement during treatment (A: baseline 9.2 ± 4.5, 5.9 ± 3.6 1 month, 3 months 4.5 ± 3.1, p <0 05 / D: baseline 5.5 ± 4.1; 1 month 3 ± 3; 3 months 2.3 ± 2.1, p <0.05), in psychiatry population (A: baseline 11.3 ± 4 , 5; 1 month 7.1 ± 3.7, 5.3 ± 3.5 3 months, p <0.05 / D: baseline 7.4 ± 4.8, 4.2 ± 3.6 one month; 3 months 3 ± 2.9, p <0.05), regardless of treatment. Abstinence rate: 58.5%, unaffected by baseline levels of anxiety and depression. No significant neuropsychiatric side effects were detected. Conclusions: Anxiety and depression levels evolved favourably during the program, achieving good results regardless of the presence of psychiatric pathology.